CA
Insider
Christina Ackermann
DirectorChristina Ackermann (Director) filed 2 Form 4 reports in the past 24 months (1 purchase, 1 sale), most often in VRNA. The largest single filing was $338K of VRNA (40,000 sh × $8.44, as filed), executed May 14 2025. The median gap between execution and disclosure was 1 day.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
purchases not yet priced
Delay-adjustediThe same average, entered at disclosure dates
–
purchases not yet priced
Filings, ttm
2
1 buys · 1 sells
Median delay
1d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$536K
shares × price, as filed
Last traded
May 14 2025
Filed May 16 2025
100% of their measured filings could not be priced (delisted or unquoted names). The returns above cover only what still trades.
Open performance→Volume by month
Buys $199K
Sells $338K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Not on file
2 filings
Sector per market data · by filing · past 24 months
Most traded names
VRNA
VRNA
VRNA · 1 buy · 1 sell
2 filings
Recent filings
VRNASALE
Verona Pharma plc
View filing →
$338K40,000 sh × $8.44
Exec May 14 2025
Filed May 16 2025 · 5:30 PM ET VRNAPURCHASE Verona Pharma plc View filing → $199K
41,880 sh × $4.74
Exec Nov 6 2024
Filed Nov 7 2024 · 5:30 PM ET